Literature DB >> 16628585

Decreased bacterial clearance from the lungs of mice following primary respiratory syncytial virus infection.

James M Stark1, Marilyn A Stark, Giuseppe N Colasurdo, Ann Marie LeVine.   

Abstract

Virus respiratory infections often precede bacterial pneumonia in healthy individuals. In order to determine the potential role of respiratory syncytial virus (RSV) in bacterial secondary infections, a mouse sequential pulmonary infection model was developed. Mice were exposed to RSV then challenged with Streptococcus pneumoniae (StPn). Exposure of BALB/c mice to 10(6)-10(7) plaque forming units (pfu) of virus of RSV significantly decreased StPn clearance 1-7 days following RSV exposure. This finding was not restricted to StPn alone: exposure to RSV followed by Staphylococcus aureus (SA) or Pseudomonas aeruginosa(PA) resulted in similar decreases in bacterial clearance. Both bronchoalveolar lavage (BAL) cell counts and pulmonary histopathology demonstrated that RSV-StPn exposed mice had increased lung cellular inflammation compared to mice receiving StPn or RSV alone. The effect of RSV infection on bacterial clearance was dependent on the mouse genetic background: C57BL/6J mice (relatively resistant to RSV infection) demonstrated a modest change in StPn clearance following RSV exposure, whereas FVBN/J mice (similar to the BALB/cJ mice in RSV susceptibility) demonstrated a similar degree of RSV-associated decrease in StPn clearance 7 days following RSV exposure. Neutrophils from the RSV-StPn sequentially exposed BALB/cJ mice were functionally altered-produced greater levels of peroxide production but less myeloperoxidase (MPO) compared to mice receiving StPn alone. These data demonstrate that RSV infection decreases bacterial clearance, potentially predisposing to secondary bacterial pneumonia despite increased lung cellular inflammation, and suggest that functional changes occur in the recruited neutrophils that may contribute to the decreased bacterial clearance.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16628585     DOI: 10.1002/jmv.20631

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  41 in total

1.  Volatile fingerprinting of Pseudomonas aeruginosa and respiratory syncytial virus infection in an in vitro cystic fibrosis co-infection model.

Authors:  Giorgia Purcaro; Christiaan A Rees; Jeffrey A Melvin; Jennifer M Bomberger; Jane E Hill
Journal:  J Breath Res       Date:  2018-07-03       Impact factor: 3.262

2.  Respiratory syncytial virus infection exacerbates pneumococcal pneumonia via Gas6/Axl-mediated macrophage polarization.

Authors:  Takehiko Shibata; Airi Makino; Ruiko Ogata; Shigeki Nakamura; Toshihiro Ito; Kisaburo Nagata; Yoshihiko Terauchi; Taku Oishi; Mikiya Fujieda; Yoshimasa Takahashi; Manabu Ato
Journal:  J Clin Invest       Date:  2020-06-01       Impact factor: 14.808

Review 3.  The co-pathogenesis of influenza viruses with bacteria in the lung.

Authors:  Jonathan A McCullers
Journal:  Nat Rev Microbiol       Date:  2014-03-03       Impact factor: 60.633

Review 4.  The changing microbial epidemiology in cystic fibrosis.

Authors:  John J Lipuma
Journal:  Clin Microbiol Rev       Date:  2010-04       Impact factor: 26.132

5.  Differential impact of respiratory syncytial virus and parainfluenza virus on the frequency of acute otitis media is explained by lower adaptive and innate immune responses in otitis-prone children.

Authors:  David Verhoeven; Qingfu Xu; Michael E Pichichero
Journal:  Clin Infect Dis       Date:  2014-04-29       Impact factor: 9.079

6.  Non-typeable Haemophilus influenzae protects human airway epithelial cells from a subsequent respiratory syncytial virus challenge.

Authors:  Stacey M Hartwig; Margaret Ketterer; Michael A Apicella; Steven M Varga
Journal:  Virology       Date:  2016-08-27       Impact factor: 3.616

Review 7.  Lamb model of respiratory syncytial virus-associated lung disease: insights to pathogenesis and novel treatments.

Authors:  Mark R Ackermann
Journal:  ILAR J       Date:  2014

8.  Nasopharyngeal Microbiota, Host Transcriptome, and Disease Severity in Children with Respiratory Syncytial Virus Infection.

Authors:  Wouter A A de Steenhuijsen Piters; Santtu Heinonen; Raiza Hasrat; Eleonora Bunsow; Bennett Smith; Maria-Carmen Suarez-Arrabal; Damien Chaussabel; Daniel M Cohen; Elisabeth A M Sanders; Octavio Ramilo; Debby Bogaert; Asuncion Mejias
Journal:  Am J Respir Crit Care Med       Date:  2016-11-01       Impact factor: 21.405

9.  Neutrophil depletion causes a fatal defect in murine pulmonary Staphylococcus aureus clearance.

Authors:  Charles M Robertson; Erin E Perrone; Kevin W McConnell; W Michael Dunne; Barrett Boody; Tejal Brahmbhatt; M Julia Diacovo; Nico Van Rooijen; Lisa A Hogue; Carolyn L Cannon; Timothy G Buchman; Richard S Hotchkiss; Craig M Coopersmith
Journal:  J Surg Res       Date:  2008-03-13       Impact factor: 2.192

10.  Antiviral activity of Nrf2 in a murine model of respiratory syncytial virus disease.

Authors:  Hye-Youn Cho; Farhad Imani; Laura Miller-DeGraff; Dianne Walters; Guillermina A Melendi; Masayuki Yamamoto; Fernando P Polack; Steven R Kleeberger
Journal:  Am J Respir Crit Care Med       Date:  2008-10-17       Impact factor: 21.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.